Literature DB >> 14670331

Protective immunity induced in mice by F0 and FII antigens purified from Paracoccidioides brasiliensis.

S N Diniz1, B S Reis, T S Goes, C S Zouain, M F Leite, A M Goes.   

Abstract

Paracoccidioides brasiliensis causes a chronic granulomatous mycosis prevalent in South America, and cell-mediated immunity represents the principal mode of protection against this fungal infection. We investigated whether immunization with P. brasiliensis antigens fractionated by anionic chromatography on fast protein liquid chromatography (FPLC) could elicit protective immunity. BALB/c mice were immunized by subcutaneous injection of either 10 microg fractions 0 (F0), II (FII) or III (FIII) in the presence of 100 microg of Corynebacterium parvum and 1 mg of Al(OH)(3) and challenged with pathogenic P. brasiliensis strain. Mice immunized with F0 presented cellular and humoral immune responses with significant production of IFN-gamma, and high levels of IgG2a and IgG3 isotypes. Immunization with FII induced significant production of IFN-gamma and IL-10 associated with high levels of IgG1 and IgG2a. It was demonstrated that immunization with F0 or FII promoted significant decrease of organ colony-forming units (CFUs) in the lung after challenge infection without fungi dissemination to the spleen or liver. In contrast, FIII immunized mice develop a progressive disseminated disease to spleen and liver presented significant levels of INF-gamma, IL-10 or TGF-beta associated with high production of IgG1 and IgG2a with low production of IgG2b and IgG3 after challenge infection. Taken together, these findings suggest that antigens of F0 and FII are reliable vaccine candidates against the paracoccidioidomycosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14670331     DOI: 10.1016/j.vaccine.2003.07.017

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

1.  Protective effect of rPb40 as an adjuvant for chemotherapy in experimental paracoccidioidomycosis.

Authors:  V C Fernandes; E M N Martins; J N Boeloni; R Serakides; A M Goes
Journal:  Mycopathologia       Date:  2012-03-03       Impact factor: 2.574

2.  Protection induced in BALB/c mice by the high-molecular-mass (hMM) fraction of Paracoccidioides brasiliensis.

Authors:  Wander R Pavanelli; Mari S Kaminami; Juliana R Geres; Ayako Sano; Mario A Ono; I C C Camargo; Eiko N Itano
Journal:  Mycopathologia       Date:  2007-03-14       Impact factor: 2.574

3.  Mice immunization with radioattenuated yeast cells of Paracoccidiodes brasiliensis: influence of the number of immunizations.

Authors:  Estefânia Mara do Nascimento Martins; Bernardo Sgarbi Reis; Maria Aparecida de Resende; Antero Silva Ribeiro de Andrade; Alfredo Miranda Goes
Journal:  Mycopathologia       Date:  2009-04-07       Impact factor: 2.574

4.  Vaccination with heat shock protein 60 induces a protective immune response against experimental Paracoccidioides brasiliensis pulmonary infection.

Authors:  Renata de Bastos Ascenço Soares; Francisco J Gomez; Célia Maria de Almeida Soares; George S Deepe
Journal:  Infect Immun       Date:  2008-07-14       Impact factor: 3.441

5.  Additive effect of rPb27 immunization and chemotherapy in experimental paracoccidioidomycosis.

Authors:  Viviane C Fernandes; Estefânia M N Martins; Jankerle N Boeloni; Juliana B Coitinho; Rogéria Serakides; Alfredo M Goes
Journal:  PLoS One       Date:  2011-03-10       Impact factor: 3.240

6.  New advances in the development of a vaccine against paracoccidioidomycosis.

Authors:  Luiz R Travassos; C P Taborda
Journal:  Front Microbiol       Date:  2012-06-12       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.